IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bellevue Group AG

Q3 2021 Holdings

Filed 2021-11-12 | 265 holdings | $1.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Biontech SE(BNTX)SPONSORED ADS09075V102$3.5M12,7000.2%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$4.0M51,7000.2%
Beigene LTD(ONC)SPONSORED ADR07725L102$8.3M23,0000.5%
Avantor Inc(AVTR)COM05352A100$21.0M512,2161.2%
Axsome Therapeutics Inc(AXSM)COM05464T104$24.8M752,9451.4%
Charles RIV Labs Intl Inc(CRL)COM159864107$26.1M63,3291.5%
Atricure Inc(ATRC)COM04963C209$29.1M418,0161.7%
Black Diamond Therapeutics I(BDTX)COM09203E105$29.3M3,463,0001.7%
Abbvie Inc(ABBV)COM00287Y109$30.5M282,9001.8%
BIO RAD Labs Inc(BIO)CL A090572207$34.3M46,0152.0%
Adaptive Biotechnologies COR(ADPT)COM00650F109$45.4M1,336,0232.6%
Beam Therapeutics Inc(BEAM)COM07373V105$53.3M612,8213.1%
Centene Corp del(CNC)COM15135B101$71.9M1,154,5454.1%
Align Technology Inc(ALGN)COM016255101$104.5M157,0316.0%
Boston Scientific Corp(BSX)COM101137107$128.7M2,967,1277.4%
Biogen Inc(BIIB)COM09062X103$149.1M527,0008.6%
Arvinas Inc(ARVN)COM04335A105$184.2M2,241,40310.6%
Agios Pharmaceuticals Inc(AGIO)COM00847X104$200.4M4,341,99211.6%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$265.9M1,408,41815.3%
Argenx SE(ARGX)SPONSORED ADR04016X101$297.1M983,93817.1%
PreviousPage 5 of 5